Education
About Us
Working with TipRanks
Follow Us
Mynd Life Sciences Inc (MYNDF)
:MYNDF
Total Valuation
MYND Life Sciences has a market cap or net worth of $2.42M. The enterprise value is $4.85M.
Market Cap$2.42M
Enterprise Value$4.85M
Share Statistics
MYND Life Sciences has 47,817,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,817,180
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MYND Life Sciences’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of MYND Life Sciences is ―. MYND Life Sciences’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, MYND Life Sciences had revenue of 0.00 and earned -1.52M in profits. Earnings per share was -0.03.
Revenue0.00
Gross Profit-332.99K
Operating Income-1.81M
Pretax Income-1.52M
Net Income-1.52M
EBITDA-1.83M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -172.78K and capital expenditures 0.00, giving a free cash flow of -172.78K billion.
Operating Cash Flow-172.78K
Free Cash Flow-172.78K
Free Cash Flow per Share>-0.01
Dividends & Yields
MYND Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.43
52-Week Price Change-50.00%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)43.62
Average Volume (3m)1.00K
Important Dates
MYND Life Sciences upcoming earnings date is Jun 26, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateJun 26, 2025
Ex-Dividend Date―
Financial Position
MYND Life Sciences as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, MYND Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
MYND Life Sciences EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
MYND Life Sciences has $0.00 in cash and marketable securities with C$312.02K in debt, giving a net cash position of $3.00M billion.
Cash & Marketable Securities$0.00
Total DebtC$312.02K
Net Cash$3.00M
Net Cash Per Share$0.06
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for MYND Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―